19-04-2024, 01:03 AM
Medical aesthetics are employed for the improvement of the outer appearance of an individual by treating skin abnormalities, such as scars, laxity, wrinkles, moles, pigmentation, and liver spots (age spots). These medical procedures can overcome skin abnormalities by boosting collagen, reducing fine lines and wrinkles, lifting flabby skin, skin rejuvenation and can even treat signs of aging. During our research, we identified over 200 medical aesthetic companies offering various medical aesthetic products and / or devices.
Maximum number of companies are engaged in offering facial aesthetic products and / or devices. These products and devices are widely used for treating various skin abnormalities, such as scars, laxity, wrinkles, moles, pigmentation, and liver spots (age spots). This is followed by companies offering body contouring devices that can help in redefining, recreating and reshaping the body. Additionally, 38% of the players are providing various laser hair removal and IPL hair removal machines that can provide painless and long-lasting results compared to traditional hair removal approaches, such as shaving, threading, and waxing. This is followed by 24% and 15% of firms which are offering tattoo removal and nail treatment devices, respectively. Further, 14% of companies are providing breast augementation solutions, including breast aesthetic devices and breast implants.
The medical aesthetics market size is estimated to grow from USD 35 billion in 2023 to USD 102 billion by 2035, representing a CAGR of 9.4% during the forecast period 2023-2035.
Type of Product and / or Device Offered
• Botulinum toxin
• Dermal Fillers
• Chemical Peels
• Body Contouring
• Gluteal Implants
• Hair Removal
• Breast Implants
• Other Products / Devices
End User
• Hospitals
• Clincs / Med Spas and Dermatology / Cosmetology Centers
• Other end users
Distribution Channel
• Direct Distribution
• Indirect Distribution
Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Middle East and North Africa
• Latin America
Key Companies Profiled
• ADSS
• Allergan Aesthetics
• Astiland, Beijing Kes Biological Technology
• BTL Aesthetics
• Candela Medical
• Classys
• Croma Pharma
• Cynosure
• Daeyang Medical
• Establishment Labs
• Galderma
• Guangzhou Itech Aesthetics
• IBSA
• Lumenis
• Lutronic
It is worth highlighting that these facial aesthetic devices are non invasive in nature and don’t involve any surgery, making them cost-effective as well. Examples of firms offering facial aesthetic devices include (in alphabetical order) Cynosure, InMode and Lutronic. In addition, 62 players are engaged in offering dermal fillers, which are extensively used for eliminating wrinkles, smoothening facial lines and volumizing the face. Moreover, the treatment can be done in even less than 30 minutes with minimal recovery time. This is followed by 25% of the firms that are manufacturing microneedling devices that can help in boosting collagen production to achieve firm, smooth, and even tone skin.
It is interesting to note that maximum number of medical aesthetic companies were established during the time period, 2001-2020. This is indicative of the continuous emergence of players into the medical aesthetics market over the past decades, reflecting a stable and enticing industry landscape.
Europe emerged as the most prominent region, featuring the presence of 42% of the players; of which most of the players are headquartered in Italy. Examples of players headquartered in Italy include (in alphabetical order, mid-sized) Company 1, Company 2 and Company 4. This is followed by 26% of the companies based in Asia-Pacific region. Within this region, South Korea and China emerged as the base of operations for most of the companies. Notable examples of players based in South Korea include (in alphabetical order, established post-2010) Company 1 (2021), Company 2 (2020), Company 3 (2016), Company 4 (2014), Company 5 (2013), Company 6 (2012) and Company 7 (2012). In addition, we came across 48 players that are based in North America.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/medical-aesthetics-market.html
Browse More Related Reports
https://www.rootsanalysis.com/reports/ne...g/290.html
https://www.rootsanalysis.com/reports/novel-immuno-oncology-biomarker-testing-market-2019-2030/253.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
+1 (415) 800 3415
Sales@rootsanalysis.com
Maximum number of companies are engaged in offering facial aesthetic products and / or devices. These products and devices are widely used for treating various skin abnormalities, such as scars, laxity, wrinkles, moles, pigmentation, and liver spots (age spots). This is followed by companies offering body contouring devices that can help in redefining, recreating and reshaping the body. Additionally, 38% of the players are providing various laser hair removal and IPL hair removal machines that can provide painless and long-lasting results compared to traditional hair removal approaches, such as shaving, threading, and waxing. This is followed by 24% and 15% of firms which are offering tattoo removal and nail treatment devices, respectively. Further, 14% of companies are providing breast augementation solutions, including breast aesthetic devices and breast implants.
The medical aesthetics market size is estimated to grow from USD 35 billion in 2023 to USD 102 billion by 2035, representing a CAGR of 9.4% during the forecast period 2023-2035.
Type of Product and / or Device Offered
• Botulinum toxin
• Dermal Fillers
• Chemical Peels
• Body Contouring
• Gluteal Implants
• Hair Removal
• Breast Implants
• Other Products / Devices
End User
• Hospitals
• Clincs / Med Spas and Dermatology / Cosmetology Centers
• Other end users
Distribution Channel
• Direct Distribution
• Indirect Distribution
Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Middle East and North Africa
• Latin America
Key Companies Profiled
• ADSS
• Allergan Aesthetics
• Astiland, Beijing Kes Biological Technology
• BTL Aesthetics
• Candela Medical
• Classys
• Croma Pharma
• Cynosure
• Daeyang Medical
• Establishment Labs
• Galderma
• Guangzhou Itech Aesthetics
• IBSA
• Lumenis
• Lutronic
It is worth highlighting that these facial aesthetic devices are non invasive in nature and don’t involve any surgery, making them cost-effective as well. Examples of firms offering facial aesthetic devices include (in alphabetical order) Cynosure, InMode and Lutronic. In addition, 62 players are engaged in offering dermal fillers, which are extensively used for eliminating wrinkles, smoothening facial lines and volumizing the face. Moreover, the treatment can be done in even less than 30 minutes with minimal recovery time. This is followed by 25% of the firms that are manufacturing microneedling devices that can help in boosting collagen production to achieve firm, smooth, and even tone skin.
It is interesting to note that maximum number of medical aesthetic companies were established during the time period, 2001-2020. This is indicative of the continuous emergence of players into the medical aesthetics market over the past decades, reflecting a stable and enticing industry landscape.
Europe emerged as the most prominent region, featuring the presence of 42% of the players; of which most of the players are headquartered in Italy. Examples of players headquartered in Italy include (in alphabetical order, mid-sized) Company 1, Company 2 and Company 4. This is followed by 26% of the companies based in Asia-Pacific region. Within this region, South Korea and China emerged as the base of operations for most of the companies. Notable examples of players based in South Korea include (in alphabetical order, established post-2010) Company 1 (2021), Company 2 (2020), Company 3 (2016), Company 4 (2014), Company 5 (2013), Company 6 (2012) and Company 7 (2012). In addition, we came across 48 players that are based in North America.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/medical-aesthetics-market.html
Browse More Related Reports
https://www.rootsanalysis.com/reports/ne...g/290.html
https://www.rootsanalysis.com/reports/novel-immuno-oncology-biomarker-testing-market-2019-2030/253.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
+1 (415) 800 3415
Sales@rootsanalysis.com